Table 5: Characteristics of patients and monitoring of viral load in those receiving pre-emptive or therapeutic antiviral treatment.

No

Patient

Type of transplant

Therapy

Weeks of follow-up at beginning therapy (duration in weeks)

Signs and symptoms

Viral load (copies/mL) before therapy

Viral load (copies/mL) after therapy

 

ADULT RECIPIENTS

 

4 Au

Bone marrow

Acyclovir

2 (1)

Oral lesion

No HSV viremia or viruria

No virus detected

 

14 Au

Bone marrow

Acyclovir

0 (2)

Trunk lesion

JC urine: 8.2 × 103

No virus detected

 

20 Al

Bone marrow

Valganciclovir

7 (2)

asymptomatic

CMV viremia: 2.6 × 103

CMV urine: 8.7 × 102

BK urine: 1.9 × 107

No virus detected

 

27 Au

Bone marrow

Acyclovir

0 (1)

Oral lesion

HSV viremia: 2.2 × 107

No virus detected

 

33 Au

Bone marrow

Acyclovir

2 (1)

Oral lesion

No HSV viremia or viruria

BK urine: 3.7 × 102

No virus detected

 

79 Au

Bone marrow

Acyclovir

0 (1)

Genital lesion

No HSV viremia or viruria

No virus detected

 

 

Valganciclovir

 

3 (2)

 

asymptomatic

CMV viremia: 1.0 × 102

BK urine: 4.8 × 102

 

No virus detected

 

84 Al

Bone marrow

Valganciclovir

Reduction of immunosupression

8 (4)

Hemorrhagic cystitis

CMV urine: 2.1 × 104

BK urine: 1.1 × 108

BK urine: 2.2 × 103

 

90 Au

Bone marrow

Acyclovir

2 (2)

Oral lesion

HSV viremia: 1.9 × 105 HSV urine: 1.1 × 104

No virus detected

 

127 Al

Bone marrow

Valganciclovir

4 (2)

Hemorrhagic cystitis

Fever, Graft rejection

CMV urine: 1.6 × 103

JC urine: 2.4 × 103

No virus detected

 

158 Au

Bone marrow

Acyclovir

2 (1)

Oral lesion

No HSV viremia or viruria

No virus detected

 

181 Al

Bone marrow

Reduction of immunosupression

2 (2)

Hemorrhagic cystitis. Deceased

BK urine: 2.1 × 106

BK urine: 5.6 × 108

 

21

Liver

Ganciclovir + Valganciclovir

4 (4)

CMV syndrome, fever and digestive complications. Deceased

CMV viremia: 1.6 × 104

CMV urine: 1.6 × 103

BK urine: 1.9 × 104

CMV viremia: 4.2 × 104

BK urine: 2.2 × 109

 

29

Liver

Valganciclovir

2 (2)

Genital lesion

HSV viremia: 1.4 × 106

HSV 2 urine: 3.8 × 107

CMV viremia: 1.3 × 103

No virus detected

 

38

Liver

Ganciclovir + Valganciclovir

6 (1)

CNS infection, graft rejection

CMV viremia: 1.1 × 102

CMV CSF: 1.8 × 103

No virus detected

 

76

Liver

Valganciclovir

12 (4)

asymptomatic

CMV viremia: 9.9 × 103

No virus detected

 

91

Liver

Valganciclovir

0 (2)

asymptomatic

CMV viremia: 1.2 × 101

BK urine: 2.2 × 101

No virus detected

 

93

Liver

Acyclovir

8 (1)

Genital lesion

No HSV viremia or viruria

CMV urine: 1.0 × 102

No virus detected

 

101

Liver

Valganciclovir

6 (1)

Elevated AST, ALT

CMV viremia: 9.9 × 104,

BK urine: 4.8 × 104

No virus detected

 

10

kidney

Valganciclovir

10 (4)

asymptomatic

CMV viremia: 4.6 × 103

CMV urine: 2.5 × 103

No virus detected

 

11

kidney

Reduction of immunosupression

Valganciclovir

2 (15)

asymptomatic

BK urine: 1.9 × 102

BK serum: 3.2 × 102

BK urine:1.3x105

 

13 (4)

CMV viremia: 2.5 × 102

CMV urine: 7.3 × 102

 

26

kidney

Acyclovir

2 (2)

Genital lesion

HSV 2 urine: 1.6 × 104

No virus detected

 

39

kidney

Valganciclovir

2 (1)

Genital lesion and graft rejection

No virus detected in serum or urine

No virus detected

 

43

kidney

Acyclovir

4 (4)

Genital lesion

HSV2 urine: 2.0 × 103

No virus detected

 

Valganciclovir

6 (4)

asymptomatic

CMV viremia: 3.5 × 102

CMV urine: 1.5 × 103

BK urine: 1.0 × 106

No virus detected

 

44

kidney

Valganciclovir

8 (4)

asymptomatic

CMV viremia: 1.9 × 104

CMV urine: 5.0 × 103

No virus detected

 

57

kidney

Valganciclovir

6 (3)

asymptomatic

CMV viremia: 2.2 × 103

CMV urine: 1.0 × 107

No virus detected

 

82

kidney

Valganciclovir

20 (4)

asymptomatic

CMV viremia: 5.3 × 103

CMV urine: 2.3 × 103

CMV urine: 5.1 × 104

 

83

kidney

Valganciclovir

10 (1)

asymptomatic

CMV viremia: 2.4 × 107

No virus detected

 
 

87

kidney

Reduction of immunosupression

8 (4)

asymptomatic

BK urine: 9.7 × 106

BK urine: 5.4 × 109

 

Valganciclovir

10 (3)

asymptomatic

CMV viremia: 2.5 × 103

CMV urine: 6.8 × 102

No virus detected

 

100

kidney

Reduction of immunosupression

8 (3)

Hemorrhagic cystitis

BK urine: 4.5 × 108

No virus detected

 

148

kidney

Valganciclovir

0 (12)

Fever and chronic reject

CMV viremia: 8.4 × 106

CMV urine: 2.3 × 103

BK urine: 8.1 × 104

No virus detected

 

198

kidney

Valganciclovir

2 (4)

Fever, CMV syndrome

CMV viremia: 1.2 × 108

CMV urine: 1.5 × 106

BK urine: 2.8 × 108

No virus detected

 

PEDIATRIC RECIPIENTS

 

17 Al

Bone marrow

Valganciclovir

Reduction of immunosupression

2 (4)

Hemorrhagic cystitis

Deceased

CMV urine: 1.2 × 102

BK urine: 2 × 102

CMV viremia: 2.1 × 103

CMV urine: 1.4 × 104

BK urine: 4.2 × 108

 

1

Liver

Valganciclovir

14 (4)

asymptomatic

CMV viremia: 1.8 × 103

No virus detected

 

8

Liver

Valganciclovir

11 (4)

asymptomatic

CMV viremia: 2.4 × 104

No virus detected

 

22

Liver

Valganciclovir

10 (10)

Elevated AST, ALT

CMV viremia: 1.3 × 104

EBV viremia: 1.0 × 101

No virus detected

 

23

Liver

Ganciclovir + Valganciclovir

5 (5)

Elevated AST, ALT

CMV viremia: 3.1 × 104

CMV urine: 1.7 × 103

No virus detected

 

12

Kidney

Valganciclovir

20 (4)

asymptomatic

CMV and BK viremia: 1.0 × 101

CMV urine: 2.4 × 102

BK urine: 1.1 × 107

 CMV urine: 1 × 101

BK urine: 7.1 × 104

 

15

Kidney

Valganciclovir

20 (4)

Fever

CMV viremia: 3.4 × 102

CMV urine: 1.4 × 105

No virus detected

 

4 (12)

Fever and chronic reject.

CMV viremia: 3.7 × 102

CMV urine: 1.8 × 106

CMV urine: 2.1 × 105

 

18

Kidney

Valganciclovir

13 (11)

Urinary infection

CMV viremia: 1.1 × 102

No viremia

 

CMV urine: 3.1 × 103

BK urine: 1.1 × 102

CMV urine: 102

 

Abbreviations: Au: Autologous, Al: Allogeneic, AST: Aspartate Aminotransferase, ALT: Alanine Aminotransferase, CNS: Central Nervious System, CMV: Cytomegalovirus, EBV: Epstein-Barr Virus; BK: BK Virus, JC: JC Virus, HSV: Herpes Simplex Virus